Atossa Genetics Current Ratio 2012-2025 | ATOS
Atossa Genetics current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atossa Genetics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.07B | $0.01B | 12.67 |
| 2024-12-31 | $0.07B | $0.01B | 14.99 |
| 2024-09-30 | $0.08B | $0.01B | 13.30 |
| 2024-06-30 | $0.08B | $0.01B | 14.35 |
| 2024-03-31 | $0.09B | $0.01B | 16.34 |
| 2023-12-31 | $0.09B | $0.01B | 17.61 |
| 2023-09-30 | $0.10B | $0.00B | 28.35 |
| 2023-06-30 | $0.11B | $0.00B | 30.48 |
| 2023-03-31 | $0.11B | $0.00B | 37.66 |
| 2022-12-31 | $0.12B | $0.01B | 21.23 |
| 2022-09-30 | $0.12B | $0.00B | 43.03 |
| 2022-06-30 | $0.13B | $0.00B | 35.19 |
| 2022-03-31 | $0.14B | $0.00B | 58.94 |
| 2021-12-31 | $0.14B | $0.00B | 45.18 |
| 2021-09-30 | $0.14B | $0.00B | 85.33 |
| 2021-06-30 | $0.15B | $0.00B | 81.19 |
| 2021-03-31 | $0.14B | $0.00B | 102.26 |
| 2020-12-31 | $0.04B | $0.02B | 2.73 |
| 2020-09-30 | $0.01B | $0.00B | 7.23 |
| 2020-06-30 | $0.01B | $0.00B | 5.51 |
| 2020-03-31 | $0.01B | $0.00B | 12.85 |
| 2019-12-31 | $0.01B | $0.00B | 10.83 |
| 2019-09-30 | $0.02B | $0.00B | 10.48 |
| 2019-06-30 | $0.02B | $0.00B | 17.80 |
| 2019-03-31 | $0.02B | $0.00B | 13.94 |
| 2018-12-31 | $0.01B | $0.00B | 3.96 |
| 2018-09-30 | $0.01B | $0.00B | 3.92 |
| 2018-06-30 | $0.02B | $0.00B | 5.45 |
| 2018-03-31 | $0.01B | $0.00B | 7.96 |
| 2017-12-31 | $0.01B | $0.00B | 6.45 |
| 2017-09-30 | $0.00B | $0.00B | 2.75 |
| 2017-06-30 | $0.00B | $0.00B | 2.09 |
| 2017-03-31 | $0.00B | $0.00B | 1.96 |
| 2016-12-31 | $0.00B | $0.00B | 3.11 |
| 2016-09-30 | $0.01B | $0.00B | 5.28 |
| 2016-06-30 | $0.00B | $0.00B | 1.66 |
| 2016-03-31 | $0.00B | $0.00B | 2.55 |
| 2015-12-31 | $0.00B | $0.00B | 1.72 |
| 2015-09-30 | $0.01B | $0.00B | 2.90 |
| 2015-06-30 | $0.01B | $0.00B | 4.03 |
| 2015-03-31 | $0.01B | $0.00B | 3.26 |
| 2014-12-31 | $0.01B | $0.00B | 4.13 |
| 2014-09-30 | $0.01B | $0.00B | 7.61 |
| 2014-06-30 | $0.02B | $0.00B | 9.39 |
| 2014-03-31 | $0.02B | $0.00B | 16.36 |
| 2013-12-31 | $0.01B | $0.00B | 4.82 |
| 2013-09-30 | $0.01B | $0.00B | 4.43 |
| 2013-06-30 | $0.01B | $0.00B | 3.02 |
| 2013-03-31 | $0.00B | $0.00B | 2.15 |
| 2012-12-31 | $0.00B | $0.00B | 1.21 |
| 2012-09-30 | $0.00B | $0.00B | 0.39 |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | 0.00 | |
| 2011-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.115B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.546B | 82.58 |
| Thermo Fisher Scientific (TMO) | United States | $162.598B | 19.67 |
| Edwards Lifesciences (EW) | United States | $46.224B | 30.31 |
| Alcon (ALC) | Switzerland | $43.751B | 29.57 |
| IDEXX Laboratories (IDXX) | United States | $43.516B | 50.01 |
| DexCom (DXCM) | United States | $33.510B | 51.79 |
| IQVIA Holdings (IQV) | United States | $28.637B | 16.04 |
| Mettler-Toledo (MTD) | United States | $25.693B | 30.56 |
| STERIS (STE) | Ireland | $22.696B | 25.00 |
| Waters (WAT) | United States | $21.023B | 29.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.706B | 0.00 |
| Hologic (HOLX) | United States | $14.897B | 16.19 |
| Sysmex ADR (SSMXY) | Japan | $10.505B | 29.80 |
| Penumbra (PEN) | United States | $9.444B | 74.12 |
| Masimo (MASI) | United States | $9.018B | 33.26 |
| Globus Medical (GMED) | United States | $7.825B | 18.65 |
| Glaukos (GKOS) | United States | $6.088B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| Integer Holdings (ITGR) | United States | $4.249B | 22.26 |
| TransMedics (TMDX) | United States | $4.221B | 91.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.276B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.545B | 15.15 |
| Veracyte (VCYT) | United States | $2.155B | 30.24 |
| Nihon Kohden (NHNKY) | Japan | $2.134B | 24.47 |
| Elekta AB (EKTAY) | Sweden | $1.961B | 17.63 |
| Alphatec Holdings (ATEC) | United States | $1.693B | 0.00 |
| Artivion (AORT) | United States | $1.390B | 130.24 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.077B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.023B | 5.44 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| IRadimed (IRMD) | United States | $0.756B | 38.37 |
| Semler Scientific (SMLR) | United States | $0.629B | 13.64 |
| Beta Bionics (BBNX) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.82 |
| AxoGen (AXGN) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.545B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.493B | 11.55 |
| Pacific Biosciences Of California (PACB) | United States | $0.450B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.391B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.267B | 0.00 |
| 908 Devices (MASS) | United States | $0.259B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.45 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.096B | 0.00 |
| Spectral AI (MDAI) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 45.80 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.023B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.69 |